AGM
VBIV

Alpine Global Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Alpine Global Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,000
Closed -$15.1K – 537
2024
Q1 		$15.1K Hold
25,000
– – ﹤0.01% 192
2023
Q4 		$14.7K Hold
25,000
– – ﹤0.01% 182
2023
Q3 		$16.7K Buy
+25,000
New +$30.6K ﹤0.01% 148
2022
Q1 		– Sell
-1,842
Closed -$129K – 763
2021
Q4 		$129K Buy
+1,842
New +$155K 0.02% 567
2021
Q3 		– Sell
-483
Closed -$49K – 388
2021
Q2 		$49K Buy
+483
New +$47.1K 0.01% 282
2018
Q3 		– Sell
-2,686
Closed -$222K – 101
2018
Q2 		$222K Buy
+2,686
New +$259K 0.11% 53

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return